@article{a57875e96a2e48fea72bc4ac058e04d0,
title = "2021 marks a new era for Alzheimer's therapeutics",
author = "Kejal Kantarci",
note = "Funding Information: I am supported by the National Institutes of Health and the Alzheimer's Drug Discovery Foundation. I have consulted for Biogen, served on the Data Safety Monitoring Board of Takeda, and received research support from Avid Radiopharmaceuticals and Eli Lilly, outside the submitted work.",
year = "2022",
month = jan,
doi = "10.1016/S1474-4422(21)00412-9",
language = "English (US)",
volume = "21",
pages = "3--4",
journal = "The Lancet Neurology",
issn = "1474-4422",
publisher = "Lancet Publishing Group",
number = "1",
}